{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T02:38:53Z","timestamp":1775615933092,"version":"3.50.1"},"reference-count":119,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,6,14]],"date-time":"2025-06-14T00:00:00Z","timestamp":1749859200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,6,14]],"date-time":"2025-06-14T00:00:00Z","timestamp":1749859200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100007601","name":"Horizon 2020","doi-asserted-by":"publisher","award":["101017884"],"award-info":[{"award-number":["101017884"]}],"id":[{"id":"10.13039\/501100007601","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["npj Digit. Med."],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>Subjective cognitive decline (SCD) is a potential early marker of neurodegeneration, with negative affective states such as depression and anxiety significantly contributing to cognitive impairment. Digital treatments show promise, yet evidence of their use and efficacy in SCD remains limited. We studied 103 individuals aged 50-65, experiencing SCD and heightened anxiety, randomly assigned to a three-week mobile app program or waitlist control. Assessments included psychological measures, immunological analysis, and for a subgroup of the participants also resting-state functional connectivity (rsFC). The intervention significantly reduced proinflammatory mediators (TNF-\u03b1, IL-17, IL-23, MCP-1, IFN-\u03b3, and IL-12) and improved depression, anxiety, resilience and well-being with sustained effect over a three-week follow-up. RsFC results show enhanced fronto-limbic connectivity correlated with the psychological and immunological changes, with the insula emerging as a key hub mediating these relationships. These findings highlight digital treatments as potential scalable, brain-immune targeted interventions for SCD and other medical conditions.<\/jats:p>","DOI":"10.1038\/s41746-025-01765-1","type":"journal-article","created":{"date-parts":[[2025,6,14]],"date-time":"2025-06-14T06:26:48Z","timestamp":1749882408000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Mobile application leads to psychological improvement and correlated neuroimmune function change in subjective cognitive decline"],"prefix":"10.1038","volume":"8","author":[{"given":"Merav","family":"Catalogna","sequence":"first","affiliation":[]},{"given":"Nira","family":"Saporta","sequence":"additional","affiliation":[]},{"given":"Bar","family":"Nathansohn-Levi","sequence":"additional","affiliation":[]},{"given":"Tal","family":"Tamir","sequence":"additional","affiliation":[]},{"given":"Ariel","family":"Shahaf","sequence":"additional","affiliation":[]},{"given":"Shira","family":"Molcho","sequence":"additional","affiliation":[]},{"given":"Shai","family":"Erlich","sequence":"additional","affiliation":[]},{"given":"Shahar","family":"Shelly","sequence":"additional","affiliation":[]},{"given":"Amir","family":"Amedi","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2025,6,14]]},"reference":[{"key":"1765_CR1","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1016\/j.jalz.2016.09.012","volume":"13","author":"JL Molinuevo","year":"2017","unstructured":"Molinuevo, J. L. et al. Implementation of subjective cognitive decline criteria in research studies. Alzheimer\u2019s Dement. 13, 296\u2013311 (2017).","journal-title":"Alzheimer\u2019s Dement."},{"key":"1765_CR2","doi-asserted-by":"crossref","unstructured":"Si, T., Xing, G. & Han, Y. Subjective cognitive decline and related cognitive deficits. Front. Neurol. 11, 274 (2020).","DOI":"10.3389\/fneur.2020.00247"},{"key":"1765_CR3","doi-asserted-by":"crossref","unstructured":"Kuhn, E. et al. Subjective cognitive decline: opposite links to neurodegeneration across the Alzheimer\u2019s continuum. Brain Commun. 3, fcab199 (2021).","DOI":"10.1093\/braincomms\/fcab199"},{"key":"1765_CR4","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1111\/acps.12336","volume":"130","author":"AJ Mitchell","year":"2014","unstructured":"Mitchell, A. J., Beaumont, H., Ferguson, D., Yadegarfar, M. & Stubbs, B. Risk of dementia and mild cognitive impairment in older people with subjective memory complaints: meta-analysis. Acta Psychiatr. Scand.130, 439\u2013451 (2014).","journal-title":"Acta Psychiatr. Scand."},{"key":"1765_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijnurstu.2023.104629","volume":"149","author":"R An","year":"2024","unstructured":"An, R. et al. Predictors of progression from subjective cognitive decline to objective cognitive impairment: a systematic review and meta-analysis of longitudinal studies. Int. J. Nurs. Stud. 149, 104629 (2024).","journal-title":"Int. J. Nurs. Stud."},{"key":"1765_CR6","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2021.101419","volume":"71","author":"R Desai","year":"2021","unstructured":"Desai, R. et al. Affective symptoms and risk of progression to mild cognitive impairment or dementia in subjective cognitive decline: a systematic review and meta-analysis. Ageing Res. Rev. 71, 101419 (2021).","journal-title":"Ageing Res. Rev."},{"key":"1765_CR7","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-04353-w","volume":"7","author":"M Srisurapanont","year":"2017","unstructured":"Srisurapanont, M., Suttajit, S., Eurviriyanukul, K. & Varnado, P. Discrepancy between objective and subjective cognition in adults with major depressive disorder. Sci. Rep. 7, 3901 (2017).","journal-title":"Sci. Rep."},{"key":"1765_CR8","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-77866-6","volume":"10","author":"T Form\u00e1nek","year":"2020","unstructured":"Form\u00e1nek, T. et al. Trajectories of depressive symptoms and associated patterns of cognitive decline. Sci. Rep. 10, 20888 (2020).","journal-title":"Sci. Rep."},{"key":"1765_CR9","doi-asserted-by":"crossref","unstructured":"Corrigan, M., O\u2019Rourke, A. M., Moran, B., Fletcher, J. M. & Harkin, A. Inflammation in the pathogenesis of depression: a disorder of neuroimmune origin. Neuronal Signal. 7, NS20220054 (2023).","DOI":"10.1042\/NS20220054"},{"key":"1765_CR10","doi-asserted-by":"publisher","first-page":"2851","DOI":"10.1111\/ejn.15239","volume":"55","author":"E Doney","year":"2022","unstructured":"Doney, E., Cadoret, A., Dion-Albert, L., Lebel, M. & Menard, C. Inflammation-driven brain and gut barrier dysfunction in stress and mood disorders. Eur. J. Neurosci. 55, 2851\u20132894 (2022).","journal-title":"Eur. J. Neurosci."},{"key":"1765_CR11","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2023.1130989","volume":"14","author":"S Hassamal","year":"2023","unstructured":"Hassamal, S. Chronic stress, neuroinflammation, and depression: an overview of pathophysiological mechanisms and emerging anti-inflammatories. Front. Psychiatry 14, 1130989 (2023).","journal-title":"Front. Psychiatry"},{"key":"1765_CR12","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1111\/ejn.14720","volume":"53","author":"R Troubat","year":"2021","unstructured":"Troubat, R. et al. Neuroinflammation and depression: a review. Eur. J. Neurosci. 53, 151\u2013171 (2021).","journal-title":"Eur. J. Neurosci."},{"key":"1765_CR13","doi-asserted-by":"publisher","first-page":"105870","DOI":"10.1016\/j.psyneuen.2022.105870","volume":"144","author":"MT Fard","year":"2022","unstructured":"Fard, M. T., Savage, K. M. & Stough, C. K. Peripheral inflammation marker relationships to cognition in healthy older adults\u2013a systematic review. Psychoneuroendocrinology 144, 105870 (2022).","journal-title":"Psychoneuroendocrinology"},{"key":"1765_CR14","doi-asserted-by":"publisher","first-page":"102182","DOI":"10.1016\/j.coi.2022.102182","volume":"76","author":"M Schwartz","year":"2022","unstructured":"Schwartz, M. & Cahalon, L. The vicious cycle governing the brain\u2013immune system relationship in neurodegenerative diseases. Curr. Opin. Immunol. 76, 102182 (2022).","journal-title":"Curr. Opin. Immunol."},{"key":"1765_CR15","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1007\/s00234-018-2100-7","volume":"60","author":"Z Guo","year":"2018","unstructured":"Guo, Z. et al. Abnormal changes in functional connectivity between the amygdala and frontal regions are associated with depression in Alzheimer\u2019s disease. Neuroradiology 60, 1315\u20131322 (2018).","journal-title":"Neuroradiology"},{"key":"1765_CR16","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.mam.2015.05.005","volume":"43","author":"PB Rosenberg","year":"2015","unstructured":"Rosenberg, P. B., Nowrangi, M. A. & Lyketsos, C. G. Neuropsychiatric symptoms in Alzheimer\u2019s disease: what might be associated brain circuits?. Mol. Asp. Med. 43, 25\u201337 (2015).","journal-title":"Mol. Asp. Med."},{"key":"1765_CR17","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2021.533428","volume":"12","author":"T Yang","year":"2021","unstructured":"Yang, T. et al. Abnormal functional connectivity of the amygdala in mild cognitive impairment patients with depression symptoms revealed by resting-state fMRI. Front. Psychiatry 12, 533428 (2021).","journal-title":"Front. Psychiatry"},{"key":"1765_CR18","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1016\/j.neubiorev.2015.07.014","volume":"56","author":"PC Mulders","year":"2015","unstructured":"Mulders, P. C., van Eijndhoven, P. F., Schene, A. H., Beckmann, C. F. & Tendolkar, I. Resting-state functional connectivity in major depressive disorder: a review. Neurosci. Biobehav. Rev. 56, 330\u2013344 (2015).","journal-title":"Neurosci. Biobehav. Rev."},{"key":"1765_CR19","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1016\/j.tics.2005.03.010","volume":"9","author":"KN Ochsner","year":"2005","unstructured":"Ochsner, K. N. & Gross, J. J. The cognitive control of emotion. Trends Cogn. Sci. 9, 242\u2013249 (2005).","journal-title":"Trends Cogn. Sci."},{"key":"1765_CR20","doi-asserted-by":"publisher","first-page":"E1","DOI":"10.1111\/j.1749-6632.2012.06751.x","volume":"1251","author":"KN Ochsner","year":"2012","unstructured":"Ochsner, K. N., Silvers, J. A. & Buhle, J. T. Functional imaging studies of emotion regulation: a synthetic review and evolving model of the cognitive control of emotion. Ann. N. Y. Acad. Sci. 1251, E1\u2013E24 (2012).","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"1765_CR21","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1007\/s00429-010-0262-0","volume":"214","author":"V Menon","year":"2010","unstructured":"Menon, V. & Uddin, L. Q. Saliency, switching, attention and control: a network model of insula function. Brain Struct. Funct. 214, 655\u2013667 (2010).","journal-title":"Brain Struct. Funct."},{"key":"1765_CR22","doi-asserted-by":"crossref","unstructured":"Zugman, A., Jett, L., Antonacci, C., Winkler, A. M. & Pine, D. S. A systematic review and meta-analysis of resting-state fMRI in anxiety disorders: need for data sharing to move the field forward. J. Anxiety Dis. 99, 102773 (2023).","DOI":"10.1016\/j.janxdis.2023.102773"},{"key":"1765_CR23","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1007\/s00429-019-02007-3","volume":"225","author":"M Yang","year":"2020","unstructured":"Yang, M., Tsai, S.-J. & Li, C.-S. R. Concurrent amygdalar and ventromedial prefrontal cortical responses during emotion processing: a meta-analysis of the effects of valence of emotion and passive exposure versus active regulation. Brain Struct. Funct. 225, 345\u2013363 (2020).","journal-title":"Brain Struct. Funct."},{"key":"1765_CR24","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/j.bbr.2009.03.004","volume":"201","author":"M Koenigs","year":"2009","unstructured":"Koenigs, M. & Grafman, J. The functional neuroanatomy of depression: distinct roles for ventromedial and dorsolateral prefrontal cortex. Behavioural Brain Res. 201, 239\u2013243 (2009).","journal-title":"Behavioural Brain Res."},{"key":"1765_CR25","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1001\/jamapsychiatry.2013.455","volume":"70","author":"J Posner","year":"2013","unstructured":"Posner, J. et al. Antidepressants normalize the default mode network in patients with dysthymia. JAMA psychiatry 70, 373\u2013382 (2013).","journal-title":"JAMA psychiatry"},{"key":"1765_CR26","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.jad.2014.09.028","volume":"172","author":"GS Dichter","year":"2015","unstructured":"Dichter, G. S., Gibbs, D. & Smoski, M. J. A systematic review of relations between resting-state functional-MRI and treatment response in major depressive disorder. J. Affect. Disord. 172, 8\u201317 (2015).","journal-title":"J. Affect. Disord."},{"key":"1765_CR27","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/j.biopsych.2009.03.015","volume":"66","author":"NA Harrison","year":"2009","unstructured":"Harrison, N. A. et al. Inflammation causes mood changes through alterations in subgenual cingulate activity and mesolimbic connectivity. Biol. Psychiatry 66, 407\u2013414 (2009).","journal-title":"Biol. Psychiatry"},{"key":"1765_CR28","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/j.bbi.2017.01.013","volume":"62","author":"AL Marsland","year":"2017","unstructured":"Marsland, A. L. et al. Systemic inflammation and resting state connectivity of the default mode network. Brain, Behav. Immun. 62, 162\u2013170 (2017).","journal-title":"Brain, Behav. Immun."},{"key":"1765_CR29","doi-asserted-by":"publisher","first-page":"1270","DOI":"10.1038\/s41423-023-01051-8","volume":"20","author":"A Rolls","year":"2023","unstructured":"Rolls, A. Immunoception: the insular cortex perspective. Cell. Mol. Immunol. 20, 1270\u20131276 (2023).","journal-title":"Cell. Mol. Immunol."},{"key":"1765_CR30","doi-asserted-by":"publisher","first-page":"e016358","DOI":"10.1136\/bmjopen-2017-016358","volume":"7","author":"NN Dhalwani","year":"2017","unstructured":"Dhalwani, N. N. et al. Association between polypharmacy and falls in older adults: a longitudinal study from England. BMJ open 7, e016358 (2017).","journal-title":"BMJ open"},{"key":"1765_CR31","doi-asserted-by":"publisher","first-page":"2114","DOI":"10.1001\/jama.2017.5706","volume":"317","author":"RM Kok","year":"2017","unstructured":"Kok, R. M. & Reynolds, C. F. Management of depression in older adults: a review. Jama 317, 2114\u20132122 (2017).","journal-title":"Jama"},{"key":"1765_CR32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11920-015-0595-8","volume":"17","author":"C Andreescu","year":"2015","unstructured":"Andreescu, C. & Varon, D. New research on anxiety disorders in the elderly and an update on evidence-based treatments. Curr. Psychiatry Rep. 17, 1\u20137 (2015).","journal-title":"Curr. Psychiatry Rep."},{"key":"1765_CR33","doi-asserted-by":"publisher","first-page":"903","DOI":"10.3233\/JAD-191295","volume":"77","author":"C Sheng","year":"2020","unstructured":"Sheng, C. et al. Advances in non-pharmacological interventions for subjective cognitive decline: A systematic review and meta-analysis. J. Alzheimer\u2019s Dis. 77, 903\u2013920 (2020).","journal-title":"J. Alzheimer\u2019s Dis."},{"key":"1765_CR34","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-024-03491-z","volume":"22","author":"X-H Yu","year":"2024","unstructured":"Yu, X.-H. et al. Effects of non-pharmacological interventions for adults with subjective cognitive decline: a network meta-analysis and component network meta-analysis. BMC Med. 22, 272 (2024).","journal-title":"BMC Med."},{"key":"1765_CR35","doi-asserted-by":"publisher","first-page":"e021610","DOI":"10.1136\/bmjopen-2018-021610","volume":"8","author":"R Bhome","year":"2018","unstructured":"Bhome, R., Berry, A. J., Huntley, J. D. & Howard, R. J. Interventions for subjective cognitive decline: systematic review and meta-analysis. BMJ Open 8, e021610 (2018).","journal-title":"BMJ Open"},{"key":"1765_CR36","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1080\/10503307.2019.1649732","volume":"30","author":"P Cuijpers","year":"2020","unstructured":"Cuijpers, P., Karyotaki, E., de Wit, L. & Ebert, D. D. The effects of fifteen evidence-supported therapies for adult depression: a meta-analytic review. Psychother. Res. 30, 279\u2013293 (2020).","journal-title":"Psychother. Res."},{"key":"1765_CR37","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1093\/bmb\/ldab005","volume":"138","author":"D Zhang","year":"2021","unstructured":"Zhang, D., Lee, E. K. P., Mak, E. C. W., Ho, C. Y. & Wong, S. Y. S. Mindfulness-based interventions: an overall review. Br. Med. Bull. 138, 41\u201357 (2021).","journal-title":"Br. Med. Bull."},{"key":"1765_CR38","doi-asserted-by":"publisher","first-page":"101931","DOI":"10.1016\/j.cpr.2020.101931","volume":"82","author":"A Rigabert","year":"2020","unstructured":"Rigabert, A. et al. Effectiveness of online psychological and psychoeducational interventions to prevent depression: Systematic review and meta-analysis of randomized controlled trials. Clin. Psychol. Rev. 82, 101931 (2020).","journal-title":"Clin. Psychol. Rev."},{"key":"1765_CR39","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1002\/jclp.22312","volume":"72","author":"MM Knowles","year":"2016","unstructured":"Knowles, M. M., Foden, P., El-Deredy, W. & Wells, A. A systematic review of efficacy of the attention training technique in clinical and nonclinical samples. J. Clin. Psychol. 72, 999\u20131025 (2016).","journal-title":"J. Clin. Psychol."},{"key":"1765_CR40","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1177\/0004867413491154","volume":"47","author":"MFDS Tursi","year":"2013","unstructured":"Tursi, M. F. D. S., Baes, C. V. W., Camacho, F. R. D. B., Tofoli, S. M. D. C. & Juruena, M. F. Effectiveness of psychoeducation for depression: a systematic review. Aust. N.Z. J. Psychiatry 47, 1019\u20131031 (2013).","journal-title":"Aust. N.Z. J. Psychiatry"},{"key":"1765_CR41","doi-asserted-by":"publisher","first-page":"102124","DOI":"10.1016\/j.cpr.2022.102124","volume":"92","author":"TJ Dunn","year":"2022","unstructured":"Dunn, T. J. & Dimolareva, M. The effect of mindfulness-based interventions on immunity-related biomarkers: a comprehensive meta-analysis of randomised controlled trials. Clin. Psychol. Rev. 92, 102124 (2022).","journal-title":"Clin. Psychol. Rev."},{"key":"1765_CR42","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1001\/jamapsychiatry.2020.0431","volume":"77","author":"GS Shields","year":"2020","unstructured":"Shields, G. S., Spahr, C. M. & Slavich, G. M. Psychosocial interventions and immune system function: a systematic review and meta-analysis of randomized clinical trials. JAMA psychiatry 77, 1031\u20131043 (2020).","journal-title":"JAMA psychiatry"},{"key":"1765_CR43","doi-asserted-by":"publisher","first-page":"1220","DOI":"10.1007\/s12671-024-02366-x","volume":"15","author":"HE Frank","year":"2024","unstructured":"Frank, H. E. et al. Mindfulness-based stress reduction health insurance coverage: if, how, and when? An integrated knowledge translation (ikt) delphi key informant analysis. Mindfulness 15, 1220\u20131233 (2024).","journal-title":"Mindfulness"},{"key":"1765_CR44","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1037\/ser0000696","volume":"20","author":"RL Shepardson","year":"2023","unstructured":"Shepardson, R. L. et al. Barriers to and facilitators of using evidence-based, cognitive\u2013behavioral anxiety interventions in integrated primary care practice. Psychol. Serv. 20, 709 (2023).","journal-title":"Psychol. Serv."},{"key":"1765_CR45","doi-asserted-by":"crossref","unstructured":"Greenwood, H., Albarqouni, L. & Thomas, R. Common barriers and enablers to the use of non-drug interventions for managing common chronic conditions in primary. BMC Prime Care. 25, 108 (2022).","DOI":"10.1186\/s12875-024-02321-8"},{"key":"1765_CR46","doi-asserted-by":"crossref","unstructured":"Ferrante, M., Esposito, L. E. & Stoeckel, L. E. From palm to practice: prescription digital therapeutics for mental and brain health at the National Institutes of Health. Front. Psychiatry 15, 1433438 (2024).","DOI":"10.3389\/fpsyt.2024.1433438"},{"key":"1765_CR47","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1097\/YCO.0000000000000906","volume":"37","author":"L Orsolini","year":"2024","unstructured":"Orsolini, L., Longo, G. & Volpe, U. Practical application of digital therapeutics in people with mood disorders. Curr. Opin. Psychiatry 37, 9\u201317 (2024).","journal-title":"Curr. Opin. Psychiatry"},{"key":"1765_CR48","unstructured":"Fortuna, K. L. et al. Digital interventions for depression and anxiety in older adults: a systematic review of randomised controlled trials. Lancet Health Longivety. 27 1277\u22121285 (2019)."},{"key":"1765_CR49","doi-asserted-by":"publisher","DOI":"10.1038\/s41746-024-01280-9","volume":"7","author":"V Cabreira","year":"2024","unstructured":"Cabreira, V., Wilkinson, T., Frostholm, L., Stone, J. & Carson, A. Systematic review and meta-analysis of standalone digital interventions for cognitive symptoms in people without dementia. npj Digital Med. 7, 278 (2024).","journal-title":"npj Digital Med."},{"key":"1765_CR50","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1007\/s00415-021-10608-4","volume":"269","author":"G Abbadessa","year":"2022","unstructured":"Abbadessa, G. et al. Digital therapeutics in neurology. J. Neurol. 269, 1209\u20131224 (2022).","journal-title":"J. Neurol."},{"key":"1765_CR51","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-025-91457-3","volume":"15","author":"M Catalogna","year":"2025","unstructured":"Catalogna, M. et al. Brain connectivity correlates of the impact of a digital intervention for individuals with subjective cognitive decline on depression and IL-18. Sci. Rep. 15, 6863 (2025).","journal-title":"Sci. Rep."},{"key":"1765_CR52","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1016\/j.cub.2023.02.025","volume":"33","author":"E Aggius-Vella","year":"2023","unstructured":"Aggius-Vella, E., Chebat, D.-R., Maidenbaum, S. & Amedi, A. Activation of human visual area V6 during egocentric navigation with and without visual experience. Curr. Biol. 33, 1211\u20131219.e1215 (2023).","journal-title":"Curr. Biol."},{"key":"1765_CR53","doi-asserted-by":"crossref","unstructured":"Amedi, A., Shelly, S., Saporta, N. & Catalogna, M. Perceptual learning and neural correlates of virtual navigation in subjective cognitive decline: a pilot study. iScience 27, 111411(2024).","DOI":"10.1016\/j.isci.2024.111411"},{"key":"1765_CR54","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1016\/j.tics.2011.08.003","volume":"15","author":"V Menon","year":"2011","unstructured":"Menon, V. Large-scale brain networks and psychopathology: a unifying triple network model. Trends Cogn. Sci. 15, 483\u2013506 (2011).","journal-title":"Trends Cogn. Sci."},{"key":"1765_CR55","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1152\/physrev.00039.2016","volume":"98","author":"R Dantzer","year":"2018","unstructured":"Dantzer, R. Neuroimmune interactions: from the brain to the immune system and vice versa. Physiol. Rev. 98, 477\u2013504 (2018).","journal-title":"Physiol. Rev."},{"key":"1765_CR56","doi-asserted-by":"publisher","first-page":"e12424","DOI":"10.1111\/spc3.12424","volume":"12","author":"WL Heppner","year":"2018","unstructured":"Heppner, W. L. & Shirk, S. D. Mindful moments: a review of brief, low-intensity mindfulness meditation and induced mindful states. Soc. Personal. Psychol. Compass 12, e12424 (2018).","journal-title":"Soc. Personal. Psychol. Compass"},{"key":"1765_CR57","doi-asserted-by":"publisher","first-page":"4412","DOI":"10.1007\/s12144-021-01762-z","volume":"42","author":"O Lahtinen","year":"2023","unstructured":"Lahtinen, O., Aaltonen, J., Kaakinen, J., Franklin, L. & Hy\u00f6n\u00e4, J. The effects of app-based mindfulness practice on the well-being of university students and staff. Curr. Psychol. 42, 4412\u20134421 (2023).","journal-title":"Curr. Psychol."},{"key":"1765_CR58","doi-asserted-by":"publisher","first-page":"100782","DOI":"10.1016\/j.jocrd.2023.100782","volume":"36","author":"A Gamoran","year":"2023","unstructured":"Gamoran, A. & Doron, G. Effectiveness of brief daily training using a mobile app in reducing obsessive compulsive disorder (OCD) symptoms: examining real world data of \u201cOCD. app-anxiety, mood & sleep\u201d. J. Obsessive Compuls. Relat. Disord. 36, 100782 (2023).","journal-title":"J. Obsessive Compuls. Relat. Disord."},{"key":"1765_CR59","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1891\/0889-8391.31.3.171","volume":"31","author":"L Hallis","year":"2017","unstructured":"Hallis, L., Cameli, L., Bekkouche, N. S. & Kn\u00e4uper, B. Combining cognitive therapy with acceptance and commitment therapy for depression: a group therapy feasibility study. J. Cogn. Psychother. 31, 171\u2013190 (2017).","journal-title":"J. Cogn. Psychother."},{"key":"1765_CR60","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.copsyc.2018.10.014","volume":"28","author":"DM Fresco","year":"2019","unstructured":"Fresco, D. M. & Mennin, D. S. All together now: Utilizing common functional change principles to unify cognitive behavioral and mindfulness-based therapies. Curr. Opin. Psychol. 28, 65\u201370 (2019).","journal-title":"Curr. Opin. Psychol."},{"key":"1765_CR61","first-page":"377","volume":"28","author":"A Pascual-Leone","year":"2005","unstructured":"Pascual-Leone, A., Amedi, A., Fregni, F. & Merabet, L. B. J. A. R. N. Plast. Hum. Brain Cortex 28, 377\u2013401 (2005).","journal-title":"Plast. Hum. Brain Cortex"},{"key":"1765_CR62","doi-asserted-by":"publisher","first-page":"S32","DOI":"10.1016\/j.jagp.2024.01.097","volume":"32","author":"P Newhouse","year":"2024","unstructured":"Newhouse, P., Morimoto, S., Vega, J., Manning, K. & Conley, A. Digital therapeutics for geriatric psychiatry: from laboratory to clinic. Am. J. Geriatr. Psychiatry 32, S32\u2013S33 (2024).","journal-title":"Am. J. Geriatr. Psychiatry"},{"key":"1765_CR63","doi-asserted-by":"publisher","first-page":"e43727","DOI":"10.2196\/43727","volume":"25","author":"A Forbes","year":"2023","unstructured":"Forbes, A., Keleher, M. R., Venditto, M. & DiBiasi, F. Assessing patient adherence to and engagement with digital interventions for depression in clinical trials: systematic literature review. J. Med. Internet Res. 25, e43727 (2023).","journal-title":"J. Med. Internet Res."},{"key":"1765_CR64","doi-asserted-by":"publisher","unstructured":"Moulton, C. D. et al. Activation of the interleukin-23\/Th17 axis in major depression: a systematic review and meta-analysis. Eur. Arch. Psychiatry Clin. Neurosci. https:\/\/doi.org\/10.1007\/s00406-024-01864-2 (2024).","DOI":"10.1007\/s00406-024-01864-2"},{"key":"1765_CR65","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2020.518837","volume":"11","author":"L Yao","year":"2020","unstructured":"Yao, L. et al. Tumor necrosis factor-\u03b1 variations in patients with major depressive disorder before and after antidepressant treatment. Front. Psychiatry 11, 518837 (2020).","journal-title":"Front. Psychiatry"},{"key":"1765_CR66","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1016\/j.bbi.2020.02.010","volume":"87","author":"EF Osimo","year":"2020","unstructured":"Osimo, E. F. et al. Inflammatory markers in depression: a meta-analysis of mean differences and variability in 5,166 patients and 5,083 controls. Brain, Behav., Immun. 87, 901\u2013909 (2020).","journal-title":"Brain, Behav., Immun."},{"key":"1765_CR67","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1016\/j.bbi.2023.05.006","volume":"111","author":"A Ballesio","year":"2023","unstructured":"Ballesio, A., Zagaria, A., Vacca, M., Pariante, C. M. & Lombardo, C. Comparative efficacy of psychological interventions on immune biomarkers: a systematic review and network meta-analysis (NMA). Brain, Behav. Immun. 111, 424\u2013435 (2023).","journal-title":"Brain, Behav. Immun."},{"key":"1765_CR68","doi-asserted-by":"publisher","first-page":"100450","DOI":"10.1016\/j.jhepr.2022.100450","volume":"4","author":"LS Alrabadi","year":"2022","unstructured":"Alrabadi, L. S. et al. Mindfulness-based stress reduction may decrease stress, disease activity, and inflammatory cytokine levels in patients with autoimmune hepatitis. JHEP Rep. 4, 100450 (2022).","journal-title":"JHEP Rep."},{"key":"1765_CR69","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1037\/ccp0000122","volume":"84","author":"E Walsh","year":"2016","unstructured":"Walsh, E., Eisenlohr-Moul, T. & Baer, R. Brief mindfulness training reduces salivary IL-6 and TNF-\u03b1 in young women with depressive symptomatology. J. Consult. Clin. Psychol. 84, 887 (2016).","journal-title":"J. Consult. Clin. Psychol."},{"key":"1765_CR70","doi-asserted-by":"crossref","unstructured":"Halpin, S. J. et al. Postdischarge symptoms and rehabilitation needs in survivors of COVID-19 infection: a cross-sectional evaluation. J. Med. Virol. 23, 1013\u22121022","DOI":"10.1002\/jmv.26368"},{"key":"1765_CR71","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.jpsychires.2016.01.008","volume":"75","author":"G Del Grande da Silva","year":"2016","unstructured":"Del Grande da Silva, G. et al. Pro-inflammatory cytokines and psychotherapy in depression: Results from a randomized clinical trial. J. Psychiatr. Res. 75, 57\u201364 (2016).","journal-title":"J. Psychiatr. Res."},{"key":"1765_CR72","first-page":"39","volume":"6","author":"A Dortaj","year":"2019","unstructured":"Dortaj, A., Moghadasi, A. N., Dehkordi, M. A. & Alipour, A. The comparison of the effectiveness of cognitive-behavioral stress management training and acceptance and commitment therapy on interleukin 12 in patients with multiple sclerosis. Int. J. Appl. Behav. Sci. 6, 39\u201350 (2019).","journal-title":"Int. J. Appl. Behav. Sci."},{"key":"1765_CR73","doi-asserted-by":"publisher","first-page":"61","DOI":"10.3389\/fnbeh.2013.00061","volume":"7","author":"JP Herman","year":"2013","unstructured":"Herman, J. P. Neural control of chronic stress adaptation. Front. Behav. Neurosci. 7, 61 (2013).","journal-title":"Front. Behav. Neurosci."},{"key":"1765_CR74","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1002\/j.2040-4603.2016.tb00694.x","volume":"6","author":"JP Herman","year":"2016","unstructured":"Herman, J. P. et al. Regulation of the hypothalamic-pituitary-adrenocortical stress response. Compr. Physiol. 6, 603 (2016).","journal-title":"Compr. Physiol."},{"key":"1765_CR75","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1037\/0278-6133.21.6.531","volume":"21","author":"GE Miller","year":"2002","unstructured":"Miller, G. E., Cohen, S. & Ritchey, A. K. Chronic psychological stress and the regulation of pro-inflammatory cytokines: a glucocorticoid-resistance model. Health Psychol. 21, 531 (2002).","journal-title":"Health Psychol."},{"key":"1765_CR76","doi-asserted-by":"crossref","unstructured":"Liu, Y.-Z., Wang, Y.-X. & Jiang, C.-L. Inflammation: The common pathway of stress-related diseases. Front. Hum. Neurosci.11, 316 (2017).","DOI":"10.3389\/fnhum.2017.00316"},{"key":"1765_CR77","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1016\/j.tins.2022.10.007","volume":"45","author":"O Kann","year":"2022","unstructured":"Kann, O., Almouhanna, F. & Chausse, B. Interferon \u03b3: a master cytokine in microglia-mediated neural network dysfunction and neurodegeneration. Trends Neurosci. 45, 913\u2013927 (2022).","journal-title":"Trends Neurosci."},{"key":"1765_CR78","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1126\/science.1252945","volume":"346","author":"K Baruch","year":"2014","unstructured":"Baruch, K. et al. Aging-induced type I interferon response at the choroid plexus negatively affects brain function. Science 346, 89\u201393 (2014).","journal-title":"Science"},{"key":"1765_CR79","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1002\/alz.12399","volume":"18","author":"HS Yang","year":"2022","unstructured":"Yang, H. S. et al. Plasma IL-12\/IFN-\u03b3 axis predicts cognitive trajectories in cognitively unimpaired older adults. Alzheimer\u2019s Dement. 18, 645\u2013653 (2022).","journal-title":"Alzheimer\u2019s Dement."},{"key":"1765_CR80","doi-asserted-by":"publisher","first-page":"3427","DOI":"10.1093\/brain\/awt259","volume":"136","author":"G Kunis","year":"2013","unstructured":"Kunis, G. et al. IFN-\u03b3-dependent activation of the brain\u2019s choroid plexus for CNS immune surveillance and repair. Brain 136, 3427\u20133440 (2013).","journal-title":"Brain"},{"key":"1765_CR81","doi-asserted-by":"publisher","first-page":"e26702","DOI":"10.1002\/hbm.26702","volume":"45","author":"J Li","year":"2024","unstructured":"Li, J., Kuang, S., Liu, Y., Wu, Y. & Li, H. Structural and functional brain alterations in subthreshold depression: a multimodal coordinate-based meta-analysis. Hum. Brain Mapp. 45, e26702 (2024).","journal-title":"Hum. Brain Mapp."},{"key":"1765_CR82","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.pscychresns.2014.02.013","volume":"222","author":"R Li","year":"2014","unstructured":"Li, R., Ma, Z., Yu, J., He, Y. & Li, J. Altered local activity and functional connectivity of the anterior cingulate cortex in elderly individuals with subthreshold depression. Psychiatry Res. Neuroimag. 222, 29\u201336 (2014).","journal-title":"Psychiatry Res. Neuroimag."},{"key":"1765_CR83","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.pnpbp.2012.11.003","volume":"41","author":"W Guo","year":"2013","unstructured":"Guo, W. et al. Decreased interhemispheric resting-state functional connectivity in first-episode, drug-naive major depressive disorder. Prog. Neuro-Psychopharmacol. Biol. Psychiatry 41, 24\u201329 (2013).","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"1765_CR84","doi-asserted-by":"publisher","first-page":"41","DOI":"10.3389\/fnsys.2010.00041","volume":"4","author":"IM Veer","year":"2010","unstructured":"Veer, I. M. et al. Whole brain resting-state analysis reveals decreased functional connectivity in major depression. Front. Syst. Neurosci. 4, 41 (2010).","journal-title":"Front. Syst. Neurosci."},{"key":"1765_CR85","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.jad.2015.03.028","volume":"179","author":"W Guo","year":"2015","unstructured":"Guo, W. et al. Decreased insular connectivity in drug-naive major depressive disorder at rest. J. Affect. Disord. 179, 31\u201337 (2015).","journal-title":"J. Affect. Disord."},{"key":"1765_CR86","doi-asserted-by":"publisher","first-page":"533","DOI":"10.2174\/1570159X15666171123201142","volume":"16","author":"JC Felger","year":"2018","unstructured":"Felger, J. C. Imaging the role of inflammation in mood and anxiety-related disorders. Curr. Neuropharmacol. 16, 533\u2013558 (2018).","journal-title":"Curr. Neuropharmacol."},{"key":"1765_CR87","doi-asserted-by":"publisher","first-page":"5902","DOI":"10.1016\/j.cell.2021.10.013","volume":"184","author":"T Koren","year":"2021","unstructured":"Koren, T. et al. Insular cortex neurons encode and retrieve specific immune responses. Cell 184, 5902\u20135915.e5917 (2021).","journal-title":"Cell"},{"key":"1765_CR88","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.jpsychires.2016.08.015","volume":"83","author":"B Patterson","year":"2016","unstructured":"Patterson, B., Boyle, M. H., Kivlenieks, M. & Van Ameringen, M. The use of waitlists as control conditions in anxiety disorders research. J. Psychiatr. Res. 83, 112\u2013120 (2016).","journal-title":"J. Psychiatr. Res."},{"key":"1765_CR89","doi-asserted-by":"publisher","first-page":"e44764","DOI":"10.2196\/44764","volume":"25","author":"E Bos","year":"2023","unstructured":"Bos, E. et al. Challenges with the use of digital sham: systematic review and recommendations. J. Med. Internet Res. 25, e44764 (2023).","journal-title":"J. Med. Internet Res."},{"key":"1765_CR90","doi-asserted-by":"publisher","first-page":"823977","DOI":"10.3389\/fdgth.2022.823977","volume":"4","author":"J Lutz","year":"2022","unstructured":"Lutz, J., Offidani, E., Taraboanta, L., Lakhan, S. E. & Campellone, T. R. Appropriate controls for digital therapeutic clinical trials: a narrative review of control conditions in clinical trials of digital therapeutics (DTx) deploying psychosocial, cognitive, or behavioral content. Front. Digital Health 4, 823977 (2022).","journal-title":"Front. Digital Health"},{"key":"1765_CR91","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1016\/j.jalz.2014.01.001","volume":"10","author":"F Jessen","year":"2014","unstructured":"Jessen, F. et al. A conceptual framework for research on subjective cognitive decline in preclinical Alzheimer\u2019s disease. Alzheimers Dement. 10, 844\u2013852 (2014).","journal-title":"Alzheimers Dement."},{"key":"1765_CR92","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1007\/s12144-023-04309-6","volume":"43","author":"P Ren","year":"2024","unstructured":"Ren, P. & Klausen, S. H. Smartphone use, intergenerational support and older adults\u2019 wellbeing. Curr. Psychol. 43, 407\u2013424 (2024).","journal-title":"Curr. Psychol."},{"key":"1765_CR93","unstructured":"Gelles-Watnick, R. Americans\u2019 use of mobile technology and home broadband. Pew Res. Center (2024)."},{"key":"1765_CR94","doi-asserted-by":"crossref","unstructured":"Fulop, T. et al. Immunology of aging: the birth of inflammaging. Clin. Rev. Allergy Immunol. 64, 109\u2212122 (2021).","DOI":"10.1007\/s12016-021-08899-6"},{"key":"1765_CR95","doi-asserted-by":"publisher","first-page":"586","DOI":"10.3389\/fimmu.2018.00586","volume":"9","author":"IM Rea","year":"2018","unstructured":"Rea, I. M. et al. Age and age-related diseases: role of inflammation triggers and cytokines. Front. Immunol. 9, 586 (2018).","journal-title":"Front. Immunol."},{"key":"1765_CR96","doi-asserted-by":"crossref","unstructured":"Schwartz, M. & Colaiuta, S. P. Boosting peripheral immunity to fight neurodegeneration in the brain. Trends Immunol. 45, 760\u2212767 (2024).","DOI":"10.1016\/j.it.2024.08.002"},{"key":"1765_CR97","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1007\/s00018-013-1459-1","volume":"71","author":"Y Yao","year":"2014","unstructured":"Yao, Y. & Tsirka, S. E. Monocyte chemoattractant protein-1 and the blood\u2013brain barrier. Cell. Mol. life Sci. 71, 683\u2013697 (2014).","journal-title":"Cell. Mol. life Sci."},{"key":"1765_CR98","doi-asserted-by":"publisher","first-page":"861231","DOI":"10.1155\/2014\/861231","volume":"2014","author":"G Olmos","year":"2014","unstructured":"Olmos, G. & Llad\u00f3, J. Tumor necrosis factor alpha: a link between neuroinflammation and excitotoxicity. Med. Inflamm. 2014, 861231 (2014).","journal-title":"Med. Inflamm."},{"key":"1765_CR99","doi-asserted-by":"publisher","first-page":"639353","DOI":"10.3389\/fneur.2021.639353","volume":"12","author":"L Nitsch","year":"2021","unstructured":"Nitsch, L., Schneider, L., Zimmermann, J. & M\u00fcller, M. Microglia-Derived interleukin 23: a crucial cytokine in Alzheimer\u2019s disease?. Front. Neurol. 12, 639353 (2021).","journal-title":"Front. Neurol."},{"key":"1765_CR100","doi-asserted-by":"publisher","first-page":"947","DOI":"10.3389\/fimmu.2020.00947","volume":"11","author":"J Milovanovic","year":"2020","unstructured":"Milovanovic, J. et al. Interleukin-17 in chronic inflammatory neurological diseases. Front. Immunol. 11, 947 (2020).","journal-title":"Front. Immunol."},{"key":"1765_CR101","doi-asserted-by":"publisher","first-page":"eabo7649","DOI":"10.1126\/science.abo7649","volume":"380","author":"G Castellani","year":"2023","unstructured":"Castellani, G., Croese, T., Peralta Ramos, J. M. & Schwartz, M. Transforming the understanding of brain immunity. Science 380, eabo7649 (2023).","journal-title":"Science"},{"key":"1765_CR102","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1159\/000506861","volume":"4","author":"A Palanica","year":"2020","unstructured":"Palanica, A., Docktor, M. J., Lieberman, M. & Fossat, Y. The need for artificial intelligence in digital therapeutics. Digital Biomark. 4, 21\u201325 (2020).","journal-title":"Digital Biomark."},{"key":"1765_CR103","first-page":"856","volume":"6","author":"EE Lee","year":"2021","unstructured":"Lee, E. E. et al. Artificial intelligence for mental health care: clinical applications, barriers, facilitators, and artificial wisdom. Biol. Psychiatry. Cogn. Neurosci. Neuroimaging 6, 856\u2013864 (2021).","journal-title":"Biol. Psychiatry. Cogn. Neurosci. Neuroimaging"},{"key":"1765_CR104","doi-asserted-by":"publisher","first-page":"403","DOI":"10.3390\/jcm13020403","volume":"13","author":"Z Biskupiak","year":"2024","unstructured":"Biskupiak, Z., Ha, V. V., Rohaj, A. & Bulaj, G. Digital therapeutics for improving effectiveness of pharmaceutical drugs and biological products: preclinical and clinical studies supporting development of drug+ digital combination therapies for chronic diseases. J. Clin. Med. 13, 403 (2024).","journal-title":"J. Clin. Med."},{"key":"1765_CR105","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1007\/s10787-023-01192-2","volume":"31","author":"M Alrouji","year":"2023","unstructured":"Alrouji, M., Al-Kuraishy, H. M., Al-Gareeb, A. I., Saad, H. M. & Batiha, G. E.-S. A story of the potential effect of non-steroidal anti-inflammatory drugs (NSAIDs) in Parkinson\u2019s disease: beneficial or detrimental effects. Inflammopharmacology 31, 673\u2013688 (2023).","journal-title":"Inflammopharmacology"},{"key":"1765_CR106","doi-asserted-by":"publisher","first-page":"1166","DOI":"10.1177\/0269881117724352","volume":"31","author":"MI Husain","year":"2017","unstructured":"Husain, M. I. et al. Minocycline as an adjunct for treatment-resistant depressive symptoms: a pilot randomised placebo-controlled trial. J. Psychopharmacol. 31, 1166\u20131175 (2017).","journal-title":"J. Psychopharmacol."},{"key":"1765_CR107","doi-asserted-by":"publisher","first-page":"2605","DOI":"10.3390\/ijms21072605","volume":"21","author":"S Zappavigna","year":"2020","unstructured":"Zappavigna, S. et al. Anti-inflammatory drugs as anticancer agents. Int. J. Mol. Sci. 21, 2605 (2020).","journal-title":"Int. J. Mol. Sci."},{"key":"1765_CR108","doi-asserted-by":"publisher","first-page":"113223","DOI":"10.1016\/j.psychres.2020.113223","volume":"291","author":"AN Zsido","year":"2020","unstructured":"Zsido, A. N., Teleki, S. A., Csokasi, K., Rozsa, S. & Bandi, S. A. Development of the short version of the spielberger state\u2014trait anxiety inventory. Psychiatry Res. 291, 113223 (2020).","journal-title":"Psychiatry Res."},{"key":"1765_CR109","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/S1474-4422(19)30368-0","volume":"19","author":"F Jessen","year":"2020","unstructured":"Jessen, F. et al. The characterisation of subjective cognitive decline. Lancet Neurol. 19, 271\u2013278 (2020).","journal-title":"Lancet Neurol."},{"key":"1765_CR110","doi-asserted-by":"crossref","unstructured":"Cohen, S., Kamarck, T., Mermelstein, R. J. J. o. h. & Behavior, S. A global measure of perceived stress. J. Health Soc. Behav. 24, 385\u2212396 (1983).","DOI":"10.2307\/2136404"},{"key":"1765_CR111","doi-asserted-by":"crossref","unstructured":"Lewinsohn, P. M., Seeley, J. R., Roberts, R. E., & Allen, N. B. Center for Epidemiologic Studies Depression Scale (CES-D) as a screening instrument for depression among community-residing older adults. Psychol. Aging 12, 277 (1997).","DOI":"10.1037\/\/0882-7974.12.2.277"},{"key":"1765_CR112","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1002\/jclp.20741","volume":"67","author":"SM Lamers","year":"2011","unstructured":"Lamers, S. M., Westerhof, G. J., Bohlmeijer, E. T., ten Klooster, P. M. & Keyes, C. L. Evaluating the psychometric properties of the mental health continuum-short form (MHC-SF). J. Clin. Psychol. 67, 99\u2013110 (2011).","journal-title":"J. Clin. Psychol."},{"key":"1765_CR113","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1177\/1073191103258144","volume":"11","author":"VG Sinclair","year":"2004","unstructured":"Sinclair, V. G. & Wallston, K. A. The development and psychometric evaluation of the brief resilient coping scale. Assessment 11, 94\u2013101 (2004).","journal-title":"Assessment"},{"key":"1765_CR114","doi-asserted-by":"publisher","first-page":"e15710","DOI":"10.1371\/journal.pone.0015710","volume":"5","author":"DA Feinberg","year":"2010","unstructured":"Feinberg, D. A. et al. Multiplexed echo planar imaging for sub-second whole brain FMRI and fast diffusion imaging. PloS ONE 5, e15710 (2010).","journal-title":"PloS ONE"},{"key":"1765_CR115","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.1002\/mrm.22361","volume":"63","author":"S Moeller","year":"2010","unstructured":"Moeller, S. et al. Multiband multislice GE-EPI at 7 tesla, with 16-fold acceleration using partial parallel imaging with application to high spatial and temporal whole-brain fMRI. Magn. Reson. Med. 63, 1144\u20131153 (2010).","journal-title":"Magn. Reson. Med."},{"key":"1765_CR116","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1089\/brain.2012.0073","volume":"2","author":"S Whitfield-Gabrieli","year":"2012","unstructured":"Whitfield-Gabrieli, S. & Nieto-Castanon, A. Conn: a functional connectivity toolbox for correlated and anticorrelated brain networks. Brain Connect.2, 125\u2013141 (2012).","journal-title":"Brain Connect."},{"key":"1765_CR117","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.neuroimage.2007.04.042","volume":"37","author":"Y Behzadi","year":"2007","unstructured":"Behzadi, Y., Restom, K., Liau, J. & Liu, T. T. A component based noise correction method (CompCor) for BOLD and perfusion based fMRI. NeuroImage 37, 90\u2013101 (2007).","journal-title":"NeuroImage"},{"key":"1765_CR118","doi-asserted-by":"crossref","unstructured":"Glasser, M. F. et al. The human connectome project\u2019s neuroimaging approach. Nat. Neurosci. 19, 1175\u20131187 (2016).","DOI":"10.1038\/nn.4361"},{"key":"1765_CR119","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1007\/s00429-021-02421-6","volume":"227","author":"C-C Huang","year":"2022","unstructured":"Huang, C.-C., Rolls, E. T., Feng, J. & Lin, C.-P. An extended Human Connectome Project multimodal parcellation atlas of the human cortex and subcortical areas. Brain Struct. Funct. 227, 763\u2013778 (2022).","journal-title":"Brain Struct. Funct."}],"container-title":["npj Digital Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41746-025-01765-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41746-025-01765-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41746-025-01765-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,14]],"date-time":"2025-06-14T07:02:54Z","timestamp":1749884574000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41746-025-01765-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,14]]},"references-count":119,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1765"],"URL":"https:\/\/doi.org\/10.1038\/s41746-025-01765-1","relation":{},"ISSN":["2398-6352"],"issn-type":[{"value":"2398-6352","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,14]]},"assertion":[{"value":"3 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 June 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A.A. is a co-founder and employee of Remepy Health Ltd. and he holds shares of Remepy Inc. M.C., A.S., and T.T. are current or former employees of Remepy Health Ltd. and they hold stock options of Remepy, Inc. N.S., S.S. and S.M. are consultants of Remepy Health Ltd. and hold stock options of Remepy, Inc. S.E. is a consultant of Remepy Inc. and holds shares of Remepy, Inc. B.N.L. is a former employee of Remepy Health Ltd. and she holds shares of Remepy, Inc. A.A., S.S., S.E. and N.S. are named inventors in patent applications filed by Remepy Health Ltd. in connection with the App.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"359"}}